5th Edelris Symposium on AS-MS in Drug Discovery
The 5th Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery will be announced soon.
Previous events
2024 Edition
The fourth edition of the symposium opened with the presentation of new AS-MS perspectives, introducing CIAS-MS as a new technology offering the possibility to analyze by mass spectrometry, both the protein/ligand complex and its dissociated form. Various technical aspects of screening platforms dedicated to hit identification were discussed. The successes leading to the development of molecular tools to explore new targets were also presented.
2023 Edition
The program focused on the techniques developed by pharma and CRO organizations to implement AS-MS in their drug discovery process. Automated Data Processing was discussed and the synergy with other HTS technologies, particularly DELT, was emphasized.
2022 Edition
The program covered several aspects of AS-MS, featuring recent technological developments and exciting results on hot targets using various chemical matters including ultra-large libraries of peptides.
2021 Edition
The 1st Edelris Symposium highlighted the use of Affinity Selection-Mass Spectrometry (AS-MS) techniques to explore broad chemical spaces – biased collections, natural products, and large libraries.